Jean Jacques Kiladjian/LinkedIn
Oct 23, 2026, 14:29
Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared a post on LinkedIn:
“Thanks to Dr Bing Li for having organized my visit to the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences IHCAMS in Tianjin.
A stimulating afternoon of visits and discussion with Chinese colleagues and students in this amazing campus affiliated with the Chinese Academy of Medical Sciences and Peking Union Medical College, exclusively dedicated to hematological diseases with 1000 beds (including 200 for HSC transplantation), a large outpatient service, 2 buildings fully dedicated to medical research, cell biology and biobank.”
Stay updated with Hemostasis Today.
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP
-
Oct 23, 2026, 13:51Julia Barr: Blood Donation, Banter, and a Tunnock’s Teacake
-
Oct 23, 2026, 13:45Marta Velia Antonini: EuroELSO Webinar to Highlight New Evidence on ECMO Anticoagulation
-
Oct 23, 2026, 13:16Mary Cushman: Antiphospholipid Antibodies and Their Association with Ischemic Stroke
-
Oct 23, 2026, 13:07Cristina Figueroa Villalba: AABB 2026 Highlights in Transfusion Medicine and Cell Therapy
-
Oct 23, 2026, 13:02Jesus Ardila Novoa: New Therapies for ITP
-
Oct 23, 2026, 12:49Wolfgang Miesbach: Factor XI Inhibition and the Future of Precision Anticoagulation
-
Oct 23, 2026, 12:47Pier Maria Fornasari: Expanding Access to Curative Treatment for Aplastic Anaemia